Inter-alpha-trypsin inhibitor heavy chain 4, C-terminal fragment (H4CT) is a structural peptide used to study extracellular matrix stabilization and protease-inhibitor interactions. Its sequence supports examination of binding determinants within multimeric complexes. Researchers apply it to evaluate conformational motifs shaping matrix-associated domains. The peptide aids biochemical mapping of heavy-chain fragments.
CAT No: S06035
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.